ENLIVEX THERAPEUTICS LTD's ticker is ENLV and the CUSIP is M4130Y106. A total of 26 filers reported holding ENLIVEX THERAPEUTICS LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lee Capital Holdings LLC | 11,805 | $46,482 | 0.07% |
| Susquehanna International Group Ltd. | 18,887 | $72,073 | 0.03% |
| Compagnie Lombard Odier SCmA | 50,000 | $190,000 | 0.01% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 13,000 | $50,700 | 0.00% |
| WELLS FARGO & COMPANY/MN | 11,746 | $46,250 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 33,445 | $131,774 | 0.00% |
| Sargent Bickham Lagudis LLC | 15 | $59 | 0.00% |
| GOLDMAN SACHS GROUP INC | 18,908 | $74,450 | 0.00% |
| OSAIC HOLDINGS, INC. | 400 | $2,000 | 0.00% |